QIAGEN Gaithersburg, Inc., a subsidiary of QIAGEN NV, is an American company located in Gaithersburg, MD, that manufactures and supplies diagnostic devices.

Genecor, Inc. provides engineering services. The company is headquartered in Quebec City, Canada.

Ventana Medical Systems, Inc., is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. The company passionately pursues its mission to improve the lives of all patients afflicted with cancer. Ventana Medical Systems discover, develop, and deliver medical diagnostic systems and biopsy based cancer tests that are shaping the future of healthcare. As the leading supplier of cancer diagnostic systems to the pathology market, Ventana manufactures over 220 cancer tests with related instruments right here in southern Arizona for 80 countries, and most importantly, for 4 million people afflicted with cancer yearly around the world. Ventana products provide healthcare professionals with a total solution for all critical steps involved in the analysis of tissue biopsies. This pioneering company also offers premier workflow solutions to improve laboratory efficiency and preserve patient safety. Ventana is committed to accelerating the discovery and development of new cancer tests that allow pathologists to analyze patient samples at the molecular level to help determine the best course of therapy for each individual patient. Ventana enables this with its global leadership as the number one Pharma Industry Partner of Choice in the development and commercialization of companion diagnostics for cancer patients. Ventana Medical Systems is a member of the Roche Group that is drawing on powerful partnerships with world-class scientific institutions.

mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec® Histology kit and CINtec® Cytology kit as adjunct tools for the early detection and diagnosis of cervical cancer.\nThese kits are based on mtm's proprietary E6H4™ antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.\nmtm laboratories AG also has programs to identify and develop biomarker based diagnostics for other cancer indications. With its extensive and ever increasing network of clinical research institutions, academic research organizations, and medical professionals active in the field of oncology and molecular pathology, mtm has established a rapid, integrated process for the successful identification and clinical validation of molecular markers associated with cancer.

Attobio Pharmaceutical (Suzhou) Co. Ltd. engages in the development of biomedical technology and products. Its business activities include the innovation of products designed to improve the level of preventive medicine and early detection of disease to provide accurate diagnostic techniques, and the import and export of biological reagents and biotechnology. The company was founded by Xiao Jia Chang on May 7, 2012 and is headquartered in Suzhou, China.

Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA.

Hangzhou Detong Biotechnology Co., Ltd., established on 2010-01-06, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Import and export;Technology Import and Export;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class I Medical Device Leasing;Class II Medical Device Leasing;Machinery and Equipment Leasing;Machinery sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products);Instrument sales;Experimental analysis instrument sales;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Manufacturing of plastic products;Sales of plastic products;Glassware Sales;Office Supplies Sales;Paper Products Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

GenId is an electronic engineering company that delivers cost-effective and customized IT solutions.

Fujirebio Diagnostics AB develops and manufactures immunological reagents. It focuses on the development of monoclonal antibodies which fight against biochemical markers of diseases. The firm distributes products to the international biotech and diagnostic industries. The company is headquartered in Gothenburg, Sweden.

Catch by Gene, Inc. engages in the research and manufacture of therapeutic products and health diagnostic products for the treatment of Hepatitis B virus (HBV) and detection of human papillomaviruses (HPV). Its products include CBG HPV-DNA Qualitative and Identification Assay System, HBV-DNA Quantitative Assay System and HPV-DNA Genotyping Assay System. It also developed CBG Smoker Checker System which is a smoke detector kit used to test the usage of nicotine products. Catch by Gene was founded on July 31, 1979 and is headquartered in Wonju, South Korea.

Sansure Biotech, Inc. engages in the research, development, production, and sales of diagnostic reagents and instruments. It also provides third-party medical testing services. The company's products include viral hepatitis, genital infection & genetics, pediatric infection, respiratory infection, nucleic acid blood screening, scientific research, public health, animal disease, nucleic acid extraction, and biochemical series reagents; automatic nucleic acid detection reaction system, and point-of-care testing mobile molecular diagnostic system series instrument; and fluorescence polymerase chain reaction assay software. Sansure Biotech was founded on April 23, 2008 and is headquartered in Changsha, China.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Yaneng Biotechnology produces a gene diagnostic chip technology platform. They provide cervical cancer screening and hereditary disease diagnostics, such as pre pregnancy and prenatal diagnosis and screening tests, and automatic nucleic acid extractor.  They also provide resarch and development services.

Acon Biotech Hangzhou Co. Ltd. is a Chinese private company. The firm manufactures and distributes glucose meters, analyzers & related medical equipment.

Genematrix is developing new diagnostic products for various diseases by developing a globally competitive core platform technologies in the field of molecular diagnostics, which is attracting attention as a high-technology in the line of biotechnology. The Molecular Diagnostic market has high growth rates among in-vitro diagnostics markets and is a high value-added industry that is highly dependent on advanced countries since global companies prevailed the most core technologies. Genematrix, since the beginning of the company, has developed its own technologies that is globally competitive in the field of molecular diagnostics through joint research with domestic and international companies and research institutes.

Wuhan Yama Biological Engineering Co., Ltd., established on 2014-06-13, Business scope includes research and development of biological,Biochemicals(Does not include licensed operations)

Shanghai Donami Enterprise Development Co., Ltd., established on 2004-06-16, Business scope includes hospital management and consulting,business management,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),rubber products,building decoration materials,wood,auto parts,Motorcycle Accessories,Communication equipment(Except ground receiving facilities for satellite television broadcasting),metallic material,crafts,General merchandise wholesale,retail,Business Consulting,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Peking University Shenzhen Hospital is a private company headquartered in Guangdong, China. The firm operates hospitals.

Genetel Pharmaceuticals Shenzhen Co. Ltd., a subsidiary of Mingyuan Medicare Development Co. Ltd., is a company headquartered in Shenzhen, China. The firm manufactures and sells pharmaceuticals and medical instruments.